Instil Bio, Inc. - stock earnings
TIL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -67.4 million USD | ? USD |
| 2023Q2 | -18.7 million USD | ? USD |
| 2023Q1 | -56.3 million USD | ? USD |
| 2022Q4 | -53.8 million USD | ? USD |
| 2022Q3 | -56.2 million USD | ? USD |
| 2022Q2 | -59.0 million USD | ? USD |
| 2022Q1 | -54.1 million USD | ? USD |
| 2021Q4 | -55.4 million USD | ? USD |
| 2021Q3 | -43.0 million USD | ? USD |
| 2021Q2 | -35.3 million USD | ? USD |
| 2021Q1 | -23.1 million USD | ? USD |
| 2020Q4 | -17.2 million USD | ? USD |
| 2020Q3 | -7.3 million USD | 52000 USD |
| 2020Q2 | -9.2 million USD | 42000 USD |
| 2020Q1 | -4.1 million USD | 44000 USD |
TIL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -197.0 million USD | ? USD |
| 2022 | -223.2 million USD | ? USD |
| 2021 | -156.8 million USD | ? USD |
| 2020 | -37.7 million USD | 138000 USD |
| 2019 | -6.5 million USD | ? USD |
TIL
Price: $10.82
52 week price:
Earnings Per Share: -24.00 USD
P/E Ratio: -0.39
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 566200
Ebitda: -268970Market Capitalization: 72.6 million